Spain Becomes Indegene’s New Innovation Hub as It Strengthens European Footprint

The expansion bolsters AI-powered life sciences solutions across Europe
Indegene, a digital-first life sciences commercialization company, has announced the launch of its new entity in Spain, reinforcing its European presence. This strategic expansion aims to enhance Indegene’s AI-driven solutions while deepening collaborations with global pharmaceutical and biotech companies to accelerate digital transformation in life sciences commercialization.
Spain, recognized for its growing R&D investments, world-class talent pool, and a thriving life sciences innovation ecosystem, will now serve as a critical delivery hub for Indegene’s medical affairs, data analytics, creative design, engineering, digital marketing, and customer experience capabilities. The company is actively expanding its workforce in Spain, strengthening its local expertise to better serve its Europe-based clients.
Manish Gupta, Chairman and CEO of Indegene, highlighted the significance of this move, stating, “Spain is fast emerging as a key hub for life sciences companies in Europe. With our new presence, we can co-innovate and collaborate even more closely with clients, helping them leverage AI and data science to modernize commercialization and accelerate business transformation.”

Expanding Indegene’s European Footprint
With a strong presence across the UK, Germany, Ireland, and Switzerland, Indegene has been steadily growing in Europe. The launch of its Spain entity adds to its robust network of innovation centers dedicated to transforming medical content generation, omnichannel healthcare provider (HCP) engagement, and patient-centered solutions.
Further solidifying its leadership, Indegene has expanded through key acquisitions in Europe. Its acquisition of Trilogy Writing & Consulting GmbH enhanced its global capabilities in clinical, regulatory, safety, and medical content development. Additionally, its integration of DT Consulting, a UK-based healthcare consulting firm, further strengthened its ability to support digital transformation for global life sciences brands. These acquisitions, along with the new Spanish entity, reinforce Indegene’s commitment to AI-driven healthcare commercialization across Europe.

AI-Powered Transformation in Life Sciences
Indegene is among the few global companies where medical doctors and data scientists collaborate to solve complex challenges in life sciences commercialization. More than 20% of its employees come from medical backgrounds, working alongside over 600 AI and data science experts to develop cutting-edge solutions that revolutionize the industry.
Indegene’s AI-led innovations include automated medical content generation, which streamlines regulatory and scientific communication for pharma brands. Its personalized omnichannel engagement solutions enable life sciences companies to create highly tailored HCP and patient experiences. Additionally, its next-gen data analytics tools provide valuable insights to optimize commercialization strategies for leading biopharma companies.
With over 5,000 employees worldwide and 18 offices spanning North America, Europe, and Asia, Indegene continues to push the boundaries of AI-powered life sciences commercialization.

Led by Experts in AI & Life Sciences Innovation
Under the leadership of Manish Gupta, Chairman & CEO, Tarun Mathur, Chief Technology Officer, Gaurav Kapoor, EVP of Global Delivery, and Anirban Ghosh, SVP of Medical Affairs, Indegene has positioned itself as a pioneer in digital-first commercialization for pharmaceuticals, biotech, and medical device companies. With their combined expertise, Indegene is reshaping biopharma engagement strategies and setting new benchmarks in AI-driven healthcare solutions.
Indegene is a global leader in digital-first commercialization for pharmaceutical, biotech, and medical device companies. By combining deep healthcare expertise with AI, data science, and analytics, Indegene helps brands navigate the complex landscape of HCP engagement, medical affairs, and digital transformation.
With strategic hubs in the US, UK, Germany, Switzerland, and now Spain, Indegene is driving the future of AI-powered healthcare commercialization, ensuring that life sciences companies remain at the forefront of innovation.

At Prittle Prattle News, featuring you virtuously, we celebrate commitment and innovation. Led by Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.